NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences: September 9, 2026, at 10:15am ET at the Wells Fargo Healthcare Conference September 15, 2026, at 1:50pm CT at the Jefferies Healthcare Conference A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and tim.
BlackRock Inc. acquired a new stake in shares of HCA Healthcare, Inc. (NYSE: HCA) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 13,003,600 shares of the company's stock, valued at approximately $5,069,974,000. BlackRock Inc. owned approximately 6.01% of HCA Healthcare at the
On August 18, 2026, we conducted a discounted cash flow (DCF) analysis for HCA Healthcare Inc (HCA) in light of its recent price performance. The stock has expe
Assenagon Asset Management S.A. lessened its holdings in HCA Healthcare, Inc. (NYSE: HCA) by 81.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,001 shares of the company's stock after selling 63,779 shares during the period. Assenagon
Deane Retirement Strategies Inc. acquired a new stake in shares of HCA Healthcare, Inc. (NYSE: HCA) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 12,298 shares of the company's stock, valued at approximately $4,796,000. HCA Healthcare comprises 2.0%
NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare's East Florida Division, has been appointed president of HCA Healthcare's new Ambulatory Operations Group. Dr. Schlosser will succeed Dr. Michael Cuffe, who a.
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Fortinet, Inc. (NASDAQ:FTNT) is good and he likes it. “They're doing a good job,” he added.
If you purchased or acquired stock in HCA and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
